Korro Bio, Inc. (KRRO) Profit Margins
Over the twelve months to 2026-06-30, Korro Bio, Inc. (KRRO) had operating margin -4625.5%, net margin -4477.1%, free cash flow margin -2865.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
KRROKorro Bio, Inc.Follow KRRO — free
—
Price chart with a free account
- Market cap
- 176.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 24 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 44.7% | — | — | — | — | — | |
| Operating margin | -71.4% | -74.5% | -597.3% | -4047.1% | -1906.4% | -4625.5% | |
| Net margin | -64.8% | -71.7% | -602.0% | -3680.4% | -1834.5% | -4477.1% | |
| FCF margin | 114.5% | -140.2% | -561.4% | -3433.6% | -1237.2% | -2865.9% |
USD millions · SEC XBRL
Korro Bio, Inc. — questions
- What is Korro Bio, Inc.'s operating margin?
- -4625.5% over the twelve months to 2026-06-30.
- What is Korro Bio, Inc.'s net profit margin?
- -4477.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Korro Bio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.